2017 may become a very exciting year for Patricia Biasutto, sepofarsen captain. Her work, developing a novel RNA therapy for Leber congenital amaurosis 10, has progressed steadily. The team expects to start a first clinical trial this year.
ProQR recognizes the importance of advancing diversity, equity, and inclusivity (DEI) in the workplace to inspire each employee to fully thrive and to make their maximum contribution to ProQR.
… Rare Disease Day 2022 On behalf of all ProQRians, happy Rare Disease Day 2022. Both within ProQR and outside, we join the community in raising awareness …
… Day 2021 Even in lockdown we have been working hard as ProQRians to stay connected to the inherited retinal disease … awareness day due to its global reach and significance. ProQR played its part this year through personal interviews … interest in rare diseases. ProQRians for rare diseases ProQR played its part this year through personal interviews …
… sharing. In this blog we explore why companies, like ProQR, partner with other companies. Partnerships in our … across the community. Collaboration in science means ProQRians can share their findings, data, and hypotheses with …
… another There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan … develop. There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan …
… excited about RNA therapies He is one of the founders of ProQR, but even long before that Gerard Platenburg was … What can you tell us about the recent developments at ProQR? “So far, we have been very effective in bringing …
